Celleron Therapeutics An innovative oncology healthcare companyThe future of cancer therapy lies in the ability to match patients to treatments they will respond favourably to. Celleron has developed biomarkers using epigenetic techniques that match drugs to responsive disease. Their portfolio of technologies can be used to develop a new class ofmechanism-based cancer drugs. Drugs that will improve the success rates of treatment, reduce the side effects in patients and deliver more cost effective healthcare.

Celleron Therapeutics

Similar companies